The fraction of activated KIT revealed by 4G10 mAb was then quantified in GIST samples (Table 1), no correlation was found with the presence of KIT mutations (P>0.05, nonparametric Wilcoxon test). This evidence concerns the gene KIT and gastrointestinal stromal tumor.